跳至主要内容
临床试验/NCT06678698
NCT06678698招募中不适用

Acute Effect of Photobiomodulation on Blood Pressure, Endothelial Function and Arterial Stiffness in Individuals with Hypertension: a Randomized Controlled Trial

Universidade Federal de Sao Carlos2 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2024年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
48
试验地点
2
主要终点
Diastolic Blood Pressure

研究概览

简要总结

This is a randomized, double-blind and sham-controlled clinical trial that aims to evaluate and compare the acute effect of full-body photobiomodulation (PBM) and modified ILIB (Intravascular laser irradiation of blood) on blood pressure, endothelial function and arterial stiffness in individuals with hypertension. Participants (n=48) will be equally, randomly and secretly allocated into one of 4 groups: Panel Group; Panel Sham Group; Modified ILIB group; and Modified ILIB Sham Group. Participants aged 40 to 60 years old, diagnosed with hypertension and using control drugs for at least 3 months will be included. Participants will be assessed at pre- and post-intervention for: BP; endothelial function; arterial stiffness; blood nitrite; and thermography. In the post-intervention period, the ambulatory blood pressure monitoring will also be carried out. Participants will receive a single application of PBM, which, depending on the group, may be full-body irradiation from an LED panel (660 nm; 25.34 J/cm²; 42.24 mW/cm²), modified ILIB (660 nm; 42,462 J/cm²; 35.385 W/cm²), or the respective sham therapies. Data homogeneity and normality will be verified by the Levene and Shapiro-Wilk tests, which will determine the choice of subsequent tests. A statistical significance of 5% will be considered.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Sedentary or irregularly inactive individuals (IPAQ)
  • Both sexes
  • Age between 40 to 60 years old
  • Clinical diagnosis of hypertension for at least 3 months with difficulty in blood pressure control
  • Hypertension classification up to stage 2
  • Individuals who have a prescription for hypertension control drugs and have been using these drugs for at least 3 months

排除标准

  • Diabetes diagnosis
  • BMI > 30 kg/m²
  • Cardiac pacemaker use
  • Presence of arrhythmias or other decompensated cardiovascular diseases
  • Musculoskeletal, orthopedic or neurological conditions that make it unable to participate in the procedures
  • Presence of cognitive deficits that make it difficult to understand the assessments
  • Presence of active neoplasia, under suspicion or after 5 years in remission period
  • Presence of tattoos (covering a large body area, or the anterior wrist region)
  • Photosensitive drugs use
  • Pregnant women or under suspicion
  • Presence of epilepsy or seizures
  • Participants who present a systolic blood pressure ≥ 180 mmHg and/or diastolic blood pressure ≥ 110 mmHg on the day of the intervention

结局指标

主要结局

Diastolic Blood Pressure

时间窗: Acute effect (immediately post-intervention until 24 hours after)

Diastolic blood pressure measured in millimeters of mercury (mmHg)

次要结局

  • Systolic Blood Pressure(Acute effect (immediately post-intervention until 24 hours after))
  • Mean Arterial Pressure(Acute effect (immediately post-intervention until 24 hours after))
  • Endothelial Function(Acute effect (About 25 minutes post-intervention))
  • Arterial Stiffness(Acute effect (About 15 minutes post-intervention))
  • Blood Nitrite(Acute effect (1 hour post-intervention))

研究者

发起方
Universidade Federal de Sao Carlos
申办方类型
Other
责任方
Principal Investigator
主要研究者

Lara Maria Bataglia Espósito

Physical Therapist, Master's student

Universidade Federal de Sao Carlos

研究点 (2)

Loading locations...

相似试验